National Institutes of Neurological Disorders and Stroke
Detecting Cognitive Impairment, Including Dementia, in Primary Care and Other Everyday Clinical Settings for the General Public and in Health Disparities Populations
Identified in the Alzheimer’s Disease-Related Dementias Summit 2016 there unmet need to detect cognitive impairment, including dementia, in large and diverse populations seen in primary care across the United States, including in health disparities populations, when a patient, relative, or care provider indicates concern. To this end the NINDS initiated a consortium with the goal of developing simple, quick clinical paradigms to administer in a primary care clinical setting to Detecting Cognitive Impairment, Including Dementia. The mission of NINDS is to seek fundamental knowledge about the brain and nervous system and to use that knowledge to reduce the burden of neurological disease.
Roderick Corriveau, PhD
Program Director, Neurodegeneration
Division of Neuroscience
National Institutes of Neurological Disorders and Stroke
Dr. Rod Corriveau leads National Institutes of Health (NIH) planning efforts that establish research priorities toward preventing and treating Alzheimer’s disease-related dementias in the United States. He is also responsible for the National Institute of Neurological Disorders and Stroke (NINDS) vascular contributions to cognitive impairment and dementia (VCID) research portfolio. Before becoming a scientist, Rod twice represented Canada in the Junior World Speed Skating Championships. He subsequently completed a B.S. in Biochemistry at Simon Fraser University, a Ph.D. in Neuroscience at the University of California San Diego, and postdoctoral training at the University of California Berkeley. His 1998 original report that immune signaling molecules are also expressed in healthy developing neurons, where they are regulated by electrical activity, has been cited more than 350 times. As junior faculty Rod’s research program continued to focus on gene expression and the role of electrical activity in brain development, and he taught histology and embryology to medical students. He was an Assistant Professor at the Louisiana State University Health Sciences Center in New Orleans when Hurricane Katrina made landfall in 2005. He has worked with the NINDS on national programs in neurodegeneration research and biobanking since 2006.
Rebecca Hommer, MD
Program Director
Division of Clinical Research
National Institutes of Neurological Disorders and Stroke
Dr. Hommer is a program director in NINDS’s Division of Clinical Research with a background in adult, child, and adolescent psychiatry and clinical trials research. Dr. Hommer graduated from the University of Pennsylvania School of Medicine and completed residency and fellowship training in adult, child, and adolescent psychiatry in the Solnit Integrated Training Program at Yale. Her postdoctoral work included studies of the effects of acute stress on adolescent decision-making, attention biases associated with irritability, and longitudinal outcomes in irritable youth. Rebecca joined the National Institute of Mental Health Intramural Research Program in 2013, working first with the Pediatric & Developmental Neuroscience Branch on studies of autism spectrum and other neurodevelopmental disorders in very young children and pediatric OCD, and later with the Genetic Epidemiology Research Branch on studies of bipolar disorder and migraine. During her tenure with NIMH she served as a member of the Combined Neuroscience IRB & the Clinical Center Bioethics Committee and completed a detail with the Division of Translational Research. Dr. Hommer was delighted to join NINDS’s Division of Clinical Research in 2019, where she serves as the medical officer for the Early Phase Pain Investigation Clinical Network (EPPIC-Net) and is a program director for projects at the intersection of psychiatry and neurology, including neurodevelopmental disorders, functional neurologic disorders, cognition, and neuroCOVID research.
Former Program Staff
Claudia Moy, Administrative Program Director
Jordan Gladman, Health Program Specialist
Claudia Moy, PhD
Program Director
Division of Clinical Research
National Institutes of Neurological Disorders and Stroke
Dr. Moy is an epidemiologist with an interest in clinical trials methods as well as outcome measures, particularly patient-centered outcomes. She holds a doctorate in epidemiology from the University of Pittsburgh and a Master of Public Health degree from the Johns Hopkins University. Her prior experience includes a postdoctoral position in epidemiology at the University of Pittsburgh and a faculty position at the Johns Hopkins University school of medicine, where she was involved in the design, conduct and monitoring of multicenter clinical trials.
Jordan T. Gladman, PhD
Health Program Specialist
Division of Neuroscience
National Institutes of Neurological Disorders and Stroke
Dr. Gladman has a broad skill set in basic, clinical, and translational research from his time at The Ohio State University and the University of Virginia where he researched the molecular mechanism underlying muscular atrophy (SMA), myotonic dystrophy type 1 (DM1). At the National Institute of Neurological Disorders and Stroke he provides key coordination and support for the NINDS/NIH Alzheimer's Disease-Related Dementias (ADRD) extramural research program. The NINDS ADRD program is responsive to the National Plan to Address Alzheimer's disease and includes research on the Alzheimer's-related dementias as defined by the National Plan (frontotemporal, Lewy body, vascular and mixed dementias).